Moreover, the facts that a more important impact on gut microbiota was observed in patients with early metastasis (High PSA BCR) and no prostate, as well as in our mouse models of subcutaneously implanted PCa, point towards a mechanism involving prostate tumour-secreted molecules that could mediate changes in the gut microbiota homeostasis. This evidence concerns the gene BCR and prostate neoplasm.